FDA-PDS Symposium II: From Silos to Solutions

Keynote

Advancing Cancer Research Through Collaborations between Academia, Industry and Regulatory Science
Richard Pazdur, MD, Director, Office of Hematology & Oncology Products, FDA

Main Sessions

Project Data Sphere Initiative Update

  • Monica Bertagnolli, MD, Alliance for Clinical Trials in Oncology
  • Paul Kluetz, MD, FDA
  • Michael Morris, MD, Memorial Sloan Kettering Cancer Center
  • Martin Murphy, DMedSc, PhD, FASCO, Project Data Sphere
  • Mace Rothenberg, MD, Pfizer Oncology
  • Daniel Sargent, Alliance for Clinical Trials in Oncology
  • Oliver Sartor, MD, Tulane School of Medicine
  • Howard Scher, MD, Memorial Sloan Kettering Cancer Center

FDA’s Information Exchange and Data Transformation (INFORMED) Initiative Update

  • Sean Khozin, MD, MPH, FDA
  • Geoffrey Kim, MD, FDA

From Silos to Solutions: LSC and NCI/FDA Collaboration

  • Sean Khozin, FDA
  • Geoffrey Kim, FDA
  • Douglas Lowy, National Cancer Institute
  • Martin Murphy, DMedSc, PhD, FASCO
  • Mace Rothenberg, MD, Pfizer Oncology

Attendees

Astellas

AstraZeneca

Brigham & Women’s/Alliance

C-Change

EMD Serono

Helsinn

HHS

Hogan Lovells

Massachusetts General Hospital

Mayo/Alliance

Merck

MITRE

MSKCC

National Cancer Institute, NIH

Novartis

Patients & Partners, LLC

Pfizer

RTI

Sanofi

SAS

Takeda

Tulane

University of North Carolina